vs

Side-by-side financial comparison of NORTHRIM BANCORP INC (NRIM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $61.2M, roughly 1.4× NORTHRIM BANCORP INC). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 11.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 18.4%).

Northrim Bancorp Inc is a U.S. regional bank holding company based in Anchorage, Alaska. It offers commercial and consumer banking services including deposit accounts, business and personal loans, mortgage products, and wealth management solutions, serving local small businesses, individual customers and corporate clients in its operating areas.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NRIM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$61.2M
NRIM
Growing faster (revenue YoY)
PRCT
PRCT
+8.6% gap
PRCT
20.2%
11.6%
NRIM
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
18.4%
NRIM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NRIM
NRIM
PRCT
PRCT
Revenue
$61.2M
$83.1M
Net Profit
$-31.6M
Gross Margin
79.9%
64.9%
Operating Margin
27.2%
-4.1%
Net Margin
-38.1%
Revenue YoY
11.6%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-2.80
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRIM
NRIM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$61.2M
$76.4M
Q3 25
$77.2M
$83.3M
Q2 25
$61.4M
$79.2M
Q1 25
$55.8M
$69.2M
Q4 24
$54.8M
$68.2M
Q3 24
$51.0M
$58.4M
Q2 24
$46.5M
$53.4M
Net Profit
NRIM
NRIM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$27.1M
$-21.4M
Q2 25
$11.8M
$-19.6M
Q1 25
$13.3M
$-24.7M
Q4 24
$-18.9M
Q3 24
$8.8M
$-21.0M
Q2 24
$9.0M
$-25.6M
Gross Margin
NRIM
NRIM
PRCT
PRCT
Q1 26
64.9%
Q4 25
79.9%
60.6%
Q3 25
84.0%
64.8%
Q2 25
78.5%
65.4%
Q1 25
84.1%
63.9%
Q4 24
77.8%
64.0%
Q3 24
75.2%
63.2%
Q2 24
79.1%
59.0%
Operating Margin
NRIM
NRIM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
27.2%
-40.6%
Q3 25
44.8%
-27.8%
Q2 25
25.7%
-28.0%
Q1 25
31.5%
-39.7%
Q4 24
24.3%
-28.9%
Q3 24
22.8%
-38.4%
Q2 24
24.9%
-50.3%
Net Margin
NRIM
NRIM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
35.1%
-25.7%
Q2 25
19.2%
-24.7%
Q1 25
23.9%
-35.8%
Q4 24
-27.6%
Q3 24
17.3%
-35.9%
Q2 24
19.4%
-48.0%
EPS (diluted)
NRIM
NRIM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-2.80
$-0.54
Q3 25
$1.20
$-0.38
Q2 25
$2.09
$-0.35
Q1 25
$2.38
$-0.45
Q4 24
$-1.83
$-0.34
Q3 24
$0.39
$-0.40
Q2 24
$1.62
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRIM
NRIM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$12.8M
$51.7M
Stockholders' EquityBook value
$326.5M
$347.7M
Total Assets
$3.3B
$487.1M
Debt / EquityLower = less leverage
0.04×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRIM
NRIM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
NRIM
NRIM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$12.8M
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$23.0M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
NRIM
NRIM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$326.5M
$365.9M
Q3 25
$315.7M
$380.3M
Q2 25
$290.2M
$385.8M
Q1 25
$279.8M
$389.2M
Q4 24
$267.1M
$402.2M
Q3 24
$260.1M
$241.2M
Q2 24
$247.2M
$251.8M
Total Assets
NRIM
NRIM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$3.3B
$508.1M
Q3 25
$3.3B
$511.5M
Q2 25
$3.2B
$513.1M
Q1 25
$3.1B
$519.4M
Q4 24
$3.0B
$534.0M
Q3 24
$3.0B
$374.1M
Q2 24
$2.8B
$374.4M
Debt / Equity
NRIM
NRIM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.04×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.09×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRIM
NRIM
PRCT
PRCT
Operating Cash FlowLast quarter
$139.3M
Free Cash FlowOCF − Capex
$133.9M
FCF MarginFCF / Revenue
218.9%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$235.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRIM
NRIM
PRCT
PRCT
Q1 26
Q4 25
$139.3M
$-10.3M
Q3 25
$92.7M
$-6.6M
Q2 25
$-4.4M
$-15.0M
Q1 25
$16.5M
$-17.0M
Q4 24
$-8.7M
$-32.4M
Q3 24
$-201.0K
$-18.8M
Q2 24
$-38.5M
$-15.7M
Free Cash Flow
NRIM
NRIM
PRCT
PRCT
Q1 26
Q4 25
$133.9M
$-12.2M
Q3 25
$89.9M
$-9.5M
Q2 25
$-4.7M
$-17.8M
Q1 25
$16.3M
$-18.8M
Q4 24
$-9.3M
$-33.6M
Q3 24
$-330.0K
$-19.0M
Q2 24
$-39.4M
$-16.8M
FCF Margin
NRIM
NRIM
PRCT
PRCT
Q1 26
Q4 25
218.9%
-15.9%
Q3 25
116.5%
-11.4%
Q2 25
-7.7%
-22.5%
Q1 25
29.3%
-27.2%
Q4 24
-17.1%
-49.2%
Q3 24
-0.6%
-32.6%
Q2 24
-84.7%
-31.4%
Capex Intensity
NRIM
NRIM
PRCT
PRCT
Q1 26
Q4 25
8.9%
2.4%
Q3 25
3.5%
3.4%
Q2 25
0.5%
3.5%
Q1 25
0.4%
2.7%
Q4 24
1.1%
1.7%
Q3 24
0.3%
0.4%
Q2 24
1.9%
2.0%
Cash Conversion
NRIM
NRIM
PRCT
PRCT
Q1 26
Q4 25
Q3 25
3.42×
Q2 25
-0.37×
Q1 25
1.24×
Q4 24
Q3 24
-0.02×
Q2 24
-4.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NRIM
NRIM

Community Banking Segment$44.3M72%
Specialty Finance Segment$7.4M12%
Other$4.7M8%
Home Mortgage Lending Segment$3.6M6%
Credit And Debit Card$1.2M2%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons